SEARCH BY NAME

BROWSE

Browse Australian delisted companies

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Browse terminated Australian managed funds

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

BIOSIGNAL LIMITED (BOS)

Former Name ASX

SHARE PRICES

(updated weekly)

Former (or subsequent) names

 FROMTO
ONE NORTH ENTERTAINMENT LIMITED29/12/2011
RGM MEDIA LIMITED03/08/201029/12/2011
BIOSIGNAL LIMITED05/04/200403/08/2010
CTI COMMUNICATIONS LIMITED05/04/2004

Shareholder links

Our website ranking of BOS: rating 2
(2 out of 5)
COMPANY WEBSITE:

 

REGISTRY:
Boardroom Pty Ltd, Level 12, 225 George Street, Sydney NSW 2000
Tel : +61 2 9290 9600 or 1300 737 760
Fax : +61 2 9279 0664 or 1300 653 459
RegistryWebsite RegistryEmail

Company details

Address: Suite 145, Level 1 , National Innovation Centre , Australian Technology Park , EVELEIGH , NSW, AUSTRALIA, 1430
Tel:  (02) 9209 4126 Fax: (02) 9209 4306

Date first listed: 28/06/2000
Company Secretary: Mr Timothy Morrison
Sector: Pharmaceuticals & Biotechnology
Industry Group: XHJ
Activities: Human health research and development

name changed to RGM Media Limited

03/08/2010

the Company advises that ASX has approved an application by the Company for an additional waiver from listing rule 14.7 allowing the Company to issue the shares and options listed below more than 3 months and 1 month (as applicable) after the date of shareholder approval at a General Meeting held on 19 March 2010. The shares and options are as follows: • 70,000,000 fully paid ordinary shares to RGM Entertainment Pte Ltd for the Company's acquisition of RGM Group Pte Ltd; • Up to 30,000,000 fully paid ordinary shares under the Company's prospectus dated 21 April 2010 ("the Prospectus"); and • 200,000 fully paid shares and 200,000 unlisted options to Ayre Nominees Pty Ltd.

29/07/2010

advises that ASX has approved an application by the Company for a waiver from listing rule 14.7 allowing the Company to issue the shares and options listed below more than 3 months and 1 month (as applicable) after the date of shareholder approval at a General Meeting held on 19 March 2010. The shares and options are as follows: • 70,000,000 fully paid ordinary shares to RGM Entertainment Pte Ltd for the Company's acquisition of RGM Group Pte Ltd; • Up to 30,000,000 fully paid ordinary shares under the Company's prospectus dated 21 April 2010; and • 200,000 fully paid shares and 200,000 unlisted options to Ayre Nominees Pty Ltd

25/06/2010

issues a Supplementary Prospectus

18/05/2010

issues a Supplementary Prospectus

04/05/2010

issues a prospectus for the issue of 20 million Shares at an issue price of twenty cents ($0.20) each to raise $4 million, with the ability to accept oversubscriptions for up to an additional 10 million Shares ($2 million) before costs of the Offer

22/04/2010

advises that the 25:1 consolidation of Biosignal's issued capital has been completed

07/04/2010

suspended from quotation immediately, at the request of the Company, pursuant to listing rule 17.3 and paragraph 44 of Guidance Note 12 - Changes to Activities, following shareholder approval for the acquisition of RGM Entertainment Pte Ltd

19/03/2010

securities reinstated

11/02/2010

all resolutions considered at the AGM on 18 December 2009 were carried as ordinary resolutions on a show of hands

08/01/2010

company signs an equity financing agreement

14/12/2009

provides Notice of Annual General Meeting to be held on 18 December

20/11/2009

releases Annual Report

06/11/2009

signals there will be a delay in finalising the annual report

30/09/2009

the company has agreed to buy RGM Group Pte Ltd - the transaction values RGM at $35m

25/09/2009

company advises it has raised $900k by way of a convertible note

21/09/2009

company is making "substantial progess" towards the purchase of assets of RGM Entertainment Pte Ltd

02/09/2009

company releases its Preliminary Final Report

31/08/2009

the company has entered into revised definitive agreements with Commonwealth Biotechnologies Inc (NASDAQ:CBTE) for the sale of the BOS biofilm Intellectual Property

03/08/2009

the securities of Biosignal Limited (the "Company") will be suspended from quotation immediately, at the request of the Company following the Company announcing an agreement with RGM Entertainment Pte Ltd

31/07/2009

name changed from CTI Communications Limited

05/04/2004

ASX Announcements (courtesy of ASX)

 

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box. If an image appears, enter the word/figures you see in the image.

    loading Posting your comments. Please wait...

    Directors' on-market share transactions (last 5)

     

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Bruce FoyNon Exec Director
    Timothy BoydDirector

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Michael OredssonManaging Director, CEO10/08/2007
    Michael TavernerDirector26/03/2007
    Gillian TurnerDirector24/11/2006

    Date of first appointment, title may have changed.